Strategies for cancer prevention involving reduction or elimination of human exposure to environmental carcinogens may not always be possible. Inhibition of the development of cancer by the administration of chemicals may offer a practical alternative for reducing human cancer burden. However, the successful utilization of chemoprotective interventions will require solid mechanistic understanding of the action of these agents. The proposed study will investigate the mode of protective actions of dietary antioxidants (butylated hydroxytoluene, butylated hydroxyanisole and ethoxyquin) and dithiothiones, natural antioxidants found in cruciferous vegetables on aflatoxin B1 carcinogenesis. Dietary exposure of aflatoxin B1, a product of mold-related spoilage of foods, has been positively correlated with high incidences of human liver cancer in a number of underdeveloped areas of the world. This toxin is capable of covalent binding to biomolecules, especially DNA and these macromolecular adducts may pose both short and long term health risks from the resulting genotoxic lesions in people exposed to this carcinogen. Preliminary studies in our laboratories have demonstrated that a number of dietary antioxidants, including butylated hydroxytoluene, ethoxyquin and a dithiothione (oltipraz) lower the levels of DNA adduct formation by aflatoxin B1 three to seven fold when compared to control levels in rat liver following exposure in vivo. While these experiments suggest that these dietary anti-oxidants modify xenobiotic metabolizing enzymes to result in lower levels of total adduct formation, these antioxidants may also affect the kinetics of removal of these adducts from DNA in the initial 48 hours following dosage in vivo. Therefore, we specifically propose to examine the effects of dietary antioxidants on: a) the quantitative and qualitative patterns, organ specificity and repair of aflatoxin-DNA adduct formation and removal; b) the enzymological changes related to aflatoxin activation and detoxification and the kinetics of aflatoxin elimination; and c) the induction of gamma-glutamyltranspeptidase positive lesions, a short-term in vivo model for aflatoxin carcinogenesis. These studies should lead to a better understanding of antioxidant mechanisms for the inhibition of carcinogenesis and to facilitate insights into how dietary constituents may modulate the exposure status of populations to environmentally occurring carcinogens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039416-03
Application #
3178346
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1985-09-01
Project End
1988-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Wible, Ryan S; Tran, Quynh T; Fathima, Samreen et al. (2018) Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo. Mol Pharmacol 93:297-308
Johnson, Natalie M; Egner, Patricia A; Baxter, Victoria K et al. (2014) Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prev Res (Phila) 7:658-65
Fasullo, Michael; Smith, Autumn; Egner, Patricia et al. (2014) Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae. Mutat Res Genet Toxicol Environ Mutagen 761:18-26
Kensler, Kevin H; Slocum, Stephen L; Chartoumpekis, Dionysios V et al. (2014) Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice. Toxicol Sci 139:293-300
Kensler, Thomas W; Egner, Patricia A; Agyeman, Abena S et al. (2013) Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 329:163-77
Takaya, Kai; Suzuki, Takafumi; Motohashi, Hozumi et al. (2012) Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic Biol Med 53:817-27
Wogan, Gerald N; Kensler, Thomas W; Groopman, John D (2012) Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 29:249-57
Koissi, Niangoran; Shah, Niti H; Ginevan, Brandon et al. (2012) Lactone metabolite common to the carcinogens dioxane, diethylene glycol, and N-nitrosomorpholine: aqueous chemistry and failure to mediate liver carcinogenesis in the F344 rat. Chem Res Toxicol 25:1022-8
Fahey, Jed W; Talalay, Paul; Kensler, Thomas W (2012) Notes from the field: ""green"" chemoprevention as frugal medicine. Cancer Prev Res (Phila) 5:179-88
Kensler, Thomas W; Roebuck, Bill D; Wogan, Gerald N et al. (2011) Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci 120 Suppl 1:S28-48

Showing the most recent 10 out of 116 publications